Pyrazolopyrimidinone antianginal agents
US5426107A · kind A · utility
56Cited by
8References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1993 |
| Grant date | Jun 20, 1995 |
| Priority date | — |
| Expiry date | Jul 23, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof are selective cGMP PDE inhibitors which are useful in the treatment of such diseases and adverse conditions as angina, hypertension, congestive heart failure, reduced blood vessel patency, peripheral vascular disease, stroke, bronchitis, chronic asthma, allergic asthma, allergic rhinitis, glaucoma, and diseases characterized by disorders of gut motility.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.